Opaleye Management Inc. Leap Therapeutics, Inc. Transaction History

Opaleye Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.08 - $3.65 $990,080 - $1.74 Million	-476,000 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$1.35 - $4.01 $86,400 - $256,640	-64,000 Reduced 11.85%	476,000 $1.91 Million
Q2 2021 Aug 16, 2021	BUY	$1.48 - $1.92 $224,812 - $291,648	151,900 Added 39.14%	540,000 $886,000
Q1 2021 May 18, 2021	BUY	$1.82 - $3.01 $706,342 - $1.17 Million	388,100 New	388,100 $737,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $275M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.